Oncora Medical offers Oncora Patient Care, a documentation, workflow and decision‑support platform that captures data about cancer patients, treatments and clinical outcomes. The company is building a predictive modeling platform to support treatment design that minimizes toxicity and maximizes chances of cure. In September Oncora announced a partnership with Palo Alto‑based Varian Medical Systems; Varian invested $3 million to work with Oncora on precision‑medicine tools for radiation oncology. Earlier in the year Oncora completed a 16‑week accelerator program at the Texas Medical Center Innovation Institute in Houston and maintains a full‑time staff member there. CEO and cofounder David Lindsay describes the mission as improving outcomes for cancer patients by developing intuitive software tools to better collect and learn from real‑world data. Oncora Medical builds a health‑IT platform (Precision Radiation Oncology Platform) that helps radiation oncologists learn from past treatment data to improve the efficacy of radiotherapy. The company is based in Center City and focuses on product and engineering development. It recently signed a non‑paid agreement to install its platform at MD Anderson Cancer Center to deepen the partnership and inform new software development. Oncora plans to use new capital to expand engineering and product teams, including hiring a VP of Engineering. The company aims to run clinical studies by 2018 to generate data backing the efficacy of its offering. Financially, the firm is pursuing equity financing to support growth and product development. Oncora Medical is developing software to improve how oncologists access, organize and learn from past radiation treatment data. Its platform leverages historical radiation treatment data to provide tools for creating personalized treatments for future patients. The company intends to use the seed funds to establish an engineering team at its Philadelphia headquarters and complete early product installations with leading health systems. Co-founded by David Lindsay and Chris Berlind in 2014, Oncora participates in the University City Science Center’s Digital Health Accelerator. It is supported by the Ben Franklin Technology Partners of Southeastern PA, an initiative of the Pennsylvania Department of Community and Economic Development. The company recently raised $1.2M in seed funding to advance these efforts. Oncora Medical builds a data analytics platform that ingests and puts decades of cancer patient data into a usable format for radiation oncology. Its core tool lets physicians outline objectives and constraints and reuse past treatment plans to inform clinical decision-making and streamline workflow. The company was founded by M.D./Ph.D. student David Lindsay and Ph.D. computer science student Christopher Berlind after clinical observation revealed gaps in access to treatment data. Oncora leverages access to more than 100 physicians as built-in market research and is in discussions with cancer centers to pilot the technology. It is part of the Wharton Venture Initiation Program and has received funding from Dorm Room Fund plus a $5,000 grant from the Wharton Innovation Fund. The founders plan to announce a first pilot soon and to pursue seed funding prior to a formal launch.

Total raised

$6M

Funding rounds

4

Latest round

Equity

Latest activity

Oct 2019